Intraductal Papillary Neoplasm of the Bile Duct

Intraductal Papillary Neoplasm of the Bile Duct — Trials · CancerIndex

Clinical trials

Registered studies

758 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 119
Ph III recruiting: 7
Growth YoY: +13%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (106)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04507503	Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements	approved for marketing	—	—	Taiho Oncology, Inc.INDUSTRY	1	Mar 10, 2026	clinicaltrials
NCT04100694	Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor	approved for marketing	—	—	Merus B.V.INDUSTRY	0	May 20, 2025